Alper ozturk, A. Et Al. 2021. Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES , vol.19, no.3 , 156-175.

Alper ozturk, A., Namli, I., & AYGÜL, A., (2021). Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES , vol.19, no.3, 156-175.

Alper ozturk, A., Irem Namli, And ABDURRAHMAN AYGÜL. "Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity," ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES , vol.19, no.3, 156-175, 2021

Alper ozturk, A. A. Et Al. "Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity." ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES , vol.19, no.3, pp.156-175, 2021

Alper ozturk, A. Namli, I. And AYGÜL, A. (2021) . "Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity." ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES , vol.19, no.3, pp.156-175.

@article{article, author={A. Alper ozturk Et Al. }, title={Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity}, journal={ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES}, year=2021, pages={156-175} }